Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A

PURPOSE: To assess the impact of botulinum toxin type A (BTX-A) on signs and symptoms of dry eye (DE) in affected eye of hemifacial spasm (HFS) patients and to compare the prevalence of DE between affected and non-affected eye in HFS patients. PATIENTS AND METHODS: This prospective study included pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Ophthalmol
Hlavní autoři: Jariyakosol, Supharat, Uthaithammarat, Lita, Chatwichaikul, Nattakarn, Kasetsuwan, Ngamjit, Chongpison, Yuda
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090983/
https://ncbi.nlm.nih.gov/pubmed/33953536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S305817
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky